ReadyFlow

Beyond's analysis on ReadyFlow

• 2026-10-10 — MannKind’s HFSA 2026 data show Furoscix ReadyFlow can manage edema outside the hospital, widening its market opportunity

Recent news mentioning ReadyFlow

• 2026-10-10 — MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

Appears alongside

• MannKind
• HFSA
• CKD

Browse the full archive →